1	Cleavage	Cleavage	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	transcription	transcription	_	_	_	_	_	_	_
4	factor	factor	_	_	_	_	_	_	_
5	SP1	sp1	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	caspases	caspas	_	_	_	_	_	_	_
8	during	during	_	_	_	_	_	_	_
9	anti-IgM-induced	anti-igm-induced	_	_	_	_	_	_	_
10	B-cell	b-cell	_	_	_	_	_	_	_
11	apoptosis	apoptosis	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Apoptosis	Apoptosis	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	instrumental	instrumental	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	processes	process	_	_	_	_	_	_	_
7	generating	generate	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	diversity	diversity	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	B-cell	b-cell	_	_	_	_	_	_	_
13	repertoire	repertoire	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Autoreactive	autoreactive	_	_	_	_	_	_	_
2	B-cells	B-cell	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	eliminated	eliminate	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	anti-IgM	anti-igm	_	_	_	_	_	_	_
7	crosslinking	crosslinking	_	_	_	_	_	_	_
8	after	after	_	_	_	_	_	_	_
9	encountering	encounter	_	_	_	_	_	_	_
10	self-antigens	self-antigen	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	but	but	_	_	_	_	_	_	_
13	precise	precise	_	_	_	_	_	_	_
14	mechanisms	mechanism	_	_	_	_	_	_	_
15	leading	lead	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	B-cell	b-cell	_	_	_	_	_	_	_
18	apoptosis	apoptosis	_	_	_	_	_	_	_
19	are	be	_	_	_	_	_	_	_
20	still	still	_	_	_	_	_	_	_
21	not	not	_	_	_	_	_	_	_
22	well	well	_	_	_	_	_	_	_
23	understood	understand	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	report	report	_	_	_	_	_	_	_
3	here	here	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	cleavage	cleavage	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	SP1	sp1	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	human	human	_	_	_	_	_	_	_
14	Burkitt	Burkitt	_	_	_	_	_	_	_
15	lymphoma	lymphoma	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	line	line	_	_	_	_	_	_	_
18	BL60	bl60	_	_	_	_	_	_	_
19	during	during	_	_	_	_	_	_	_
20	anti-IgM-induced	anti-igm-induced	_	_	_	_	_	_	_
21	apoptosis	apoptosis	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Western	western	_	_	_	_	_	_	_
2	blot	blot	_	_	_	_	_	_	_
3	analysis	analysis	_	_	_	_	_	_	_
4	revealed	reveal	_	_	_	_	_	_	_
5	two	two	_	_	_	_	_	_	_
6	cleavage	cleavage	_	_	_	_	_	_	_
7	products	product	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	approximately	approximately	_	_	_	_	_	_	_
10	68	68	_	_	_	_	_	_	_
11	kDa	kda	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	45	45	_	_	_	_	_	_	_
14	kDa	kda	_	_	_	_	_	_	_
15	after	after	_	_	_	_	_	_	_
16	induction	induction	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	apoptosis	apoptosis	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Cleavage	Cleavage	_	_	_	_	_	_	_
2	could	could	_	_	_	_	_	_	_
3	be	be	_	_	_	_	_	_	_
4	completely	completely	_	_	_	_	_	_	_
5	inhibited	inhibit	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	zDEVD-fmk	zdevd-fmk	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	inhibitor	inhibitor	_	_	_	_	_	_	_
11	specific	specific	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	caspase	caspase	_	_	_	_	_	_	_
14	3-like	3-like	_	_	_	_	_	_	_
15	proteases	protease	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	In-vitro	in-vitro	_	_	_	_	_	_	_
2	cleavage	cleavage	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	recombinant	recombinant	_	_	_	_	_	_	_
5	SP1	sp1	_	_	_	_	_	_	_
6	by	by	_	_	_	_	_	_	_
7	recombinant	recombinant	_	_	_	_	_	_	_
8	caspase	caspase	_	_	_	_	_	_	_
9	3	3	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	CPP32	CPP32	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	or	or	_	_	_	_	_	_	_
14	caspase	caspase	_	_	_	_	_	_	_
15	7	7	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	Mch	Mch	_	_	_	_	_	_	_
18	3	3	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	results	result	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	similar	similar	_	_	_	_	_	_	_
23	cleavage	cleavage	_	_	_	_	_	_	_
24	products	product	_	_	_	_	_	_	_
25	as	as	_	_	_	_	_	_	_
26	those	those	_	_	_	_	_	_	_
27	observed	observe	_	_	_	_	_	_	_
28	in	in	_	_	_	_	_	_	_
29	vivo	vivo	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Recombinant	recombinant	_	_	_	_	_	_	_
2	caspase	caspase	_	_	_	_	_	_	_
3	6	6	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	Mch	Mch	_	_	_	_	_	_	_
6	2	2	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	primarily	primarily	_	_	_	_	_	_	_
9	generates	generate	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	68-kDa	68-kda	_	_	_	_	_	_	_
12	cleavage	cleavage	_	_	_	_	_	_	_
13	product	product	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	as	as	_	_	_	_	_	_	_
16	observed	observe	_	_	_	_	_	_	_
17	after	after	_	_	_	_	_	_	_
18	calcium	calcium	_	_	_	_	_	_	_
19	ionophore	ionophore	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	CaI	CaI	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	induced	induce	_	_	_	_	_	_	_
24	B-cell	b-cell	_	_	_	_	_	_	_
25	apoptosis.	apoptosis.	_	_	_	_	_	_	_
26	In	in	_	_	_	_	_	_	_
27	contrast	contrast	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	caspase	caspase	_	_	_	_	_	_	_
30	1	1	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	ICE	ICE	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	did	do	_	_	_	_	_	_	_
35	not	not	_	_	_	_	_	_	_
36	cleave	cleave	_	_	_	_	_	_	_
37	SP1	sp1	_	_	_	_	_	_	_
38	in	in	_	_	_	_	_	_	_
39	vitro	vitro	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	time	time	_	_	_	_	_	_	_
3	course	course	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	SP1	sp1	_	_	_	_	_	_	_
6	cleavage	cleavage	_	_	_	_	_	_	_
7	during	during	_	_	_	_	_	_	_
8	anti-IgM-induced	anti-igm-induced	_	_	_	_	_	_	_
9	apoptosis	apoptosis	_	_	_	_	_	_	_
10	is	be	_	_	_	_	_	_	_
11	paralleled	parallel	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	an	an	_	_	_	_	_	_	_
14	increase	increase	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	caspase	caspase	_	_	_	_	_	_	_
17	activity	activity	_	_	_	_	_	_	_
18	measured	measure	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	DEVD-p-nitroanilide	DEVD-p-nitroanilide	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	DEVD-pNA	DEVD-pNA	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	cleavage	cleavage	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	DNA	DNA	_	_	_	_	_	_	_
2	band-shift	band-shift	_	_	_	_	_	_	_
3	assays	assay	_	_	_	_	_	_	_
4	revealed	reveal	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	decrease	decrease	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	intensity	intensity	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	full	full	_	_	_	_	_	_	_
13	length	length	_	_	_	_	_	_	_
14	SP1/DNA	sp1/dna	_	_	_	_	_	_	_
15	complex	complex	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	an	an	_	_	_	_	_	_	_
18	increase	increase	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	intensity	intensity	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	smaller	small	_	_	_	_	_	_	_
25	complex	complex	_	_	_	_	_	_	_
26	due	due	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	binding	binding	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	one	one	_	_	_	_	_	_	_
32	SP1	sp1	_	_	_	_	_	_	_
33	cleavage	cleavage	_	_	_	_	_	_	_
34	product	product	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	By	by	_	_	_	_	_	_	_
2	Edman	Edman	_	_	_	_	_	_	_
3	sequencing	sequencing	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	could	could	_	_	_	_	_	_	_
6	identify	identify	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	caspase	caspase	_	_	_	_	_	_	_
9	3	3	_	_	_	_	_	_	_
10	cleavage	cleavage	_	_	_	_	_	_	_
11	site	site	_	_	_	_	_	_	_
12	after	after	_	_	_	_	_	_	_
13	Asp584	Asp584	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	D584AQPQAGR	D584AQPQAGR	_	_	_	_	_	_	_
16	)	)	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	generating	generate	_	_	_	_	_	_	_
19	a	a	_	_	_	_	_	_	_
20	22-kDa	22-kda	_	_	_	_	_	_	_
21	C-terminal	c-terminal	_	_	_	_	_	_	_
22	SP1	sp1	_	_	_	_	_	_	_
23	protein	protein	_	_	_	_	_	_	_
24	fragment	fragment	_	_	_	_	_	_	_
25	which	which	_	_	_	_	_	_	_
26	still	still	_	_	_	_	_	_	_
27	contains	contain	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	DNA	dna	_	_	_	_	_	_	_
30	binding	binding	_	_	_	_	_	_	_
31	site	site	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	show	show	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	cleavage	cleavage	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	human	human	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factor	factor	_	_	_	_	_	_	_
11	SP1	sp1	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	vivo	vivo	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	vitro	vitro	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	underlining	underline	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	central	central	_	_	_	_	_	_	_
21	role	role	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	caspase	caspase	_	_	_	_	_	_	_
24	3-like	3-like	_	_	_	_	_	_	_
25	proteases	protease	_	_	_	_	_	_	_
26	during	during	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	process	process	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	anti-IgM-induced	anti-igm-induced	_	_	_	_	_	_	_
31	apoptosis	apoptosis	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

